Aprogen Biologics Inc. (KRX:003060)
South Korea · Delayed Price · Currency is KRW 267.00
-11.00 (-3.96%)
Mar 18, 2026, 3:30 PM KST
Aprogen Biologics Market Cap
Aprogen Biologics has a market cap or net worth of 52.75 billion as of March 18, 2026. Its market cap has decreased by -67.32% in one year.
Market Cap
52.75B
Enterprise Value
268.79B
Revenue
74.91B
Ranking
n/a
PE Ratio
n/a
Stock Price
267.00
Market Cap Chart
Since January 5, 1996, Aprogen Biologics's market cap has increased from 3.18B to 52.75B, an increase of 1,558.57%. That is a compound annual growth rate of 9.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 54.93B | -46.44% |
| Dec 30, 2025 | 102.54B | -21.60% |
| Dec 30, 2024 | 130.79B | -31.41% |
| Dec 28, 2023 | 190.68B | -4.89% |
| Dec 29, 2022 | 200.48B | -44.42% |
| Dec 30, 2021 | 360.71B | -31.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Whan In Pharm | 156.18B |
| Jeil Pharma Holdings | 140.77B |
| HANDOK | 139.00B |
| Kyongbo Pharmaceutical | 131.01B |
| Ildong Holdings | 119.70B |
| CKD Bio | 105.71B |
| Kukje Pharma | 101.10B |
| Enzychem Lifesciences | 82.76B |